Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
The FDA approved a generic version of the GLP-1 receptor agonist liraglutide to improve glycemic control for people with type 2 diabetes ... a generic form of Novo Nordisk’s subcutaneous ...
The approval covers generic versions of two Novo Nordisk products: Victoza, used in the treatment of Type-2 Diabetes, and Saxenda, which is indicated for weight management. This marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback